Trypanosoma cruzi

Guilherme Martins Silva1, Suzane Quintana Gomes2, Carla Duque Lopes3

  • 1Center for Drug Discovery and Translational Research, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA; Computational Laboratory of Pharmaceutical Chemistry, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Av. do Café, s/n, Ribeirão Preto, SP 14040-903, Brazil.

概括

研究人员确定了包括LCQFTC11在内的新型化合物,这些化合物显示出抑制Trypanosoma cruzi蛋白酶体的潜力. 这为开发对查加斯病 (CD) 更安全的药物提供了有希望的新途径.